Cargando…
Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions
BACKGROUND: We aimed to develop a combined model of quantitative parameters derived from 3 different magnetic resonance imaging (MRI) diffusion models and laboratory data related to prostate-specific antigen (PSA) for differentiating between prostate cancer (PCa) and benign lesions. MATERIAL/METHODS...
Autores principales: | Han, Liying, He, Guanyong, Mei, Yingjie, Yu, Qing, Zhao, Minning, Luo, Fu, Cheng, Guanxun, Liang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044910/ https://www.ncbi.nlm.nih.gov/pubmed/35459760 http://dx.doi.org/10.12659/MSM.935307 |
Ejemplares similares
-
Role of diffusion-weighted magnetic resonance imaging in the differentiation of benign and malignant pulmonary lesions
por: Alnaghy, Eman Abdelaziz, et al.
Publicado: (2018) -
Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study
por: Yang, Lu, et al.
Publicado: (2023) -
Quantification of Multi-Parametric Magnetic Resonance Imaging Based on Radiomics Analysis for Differentiation of Benign and Malignant Lesions of Prostate
por: Koopaei, Soheila, et al.
Publicado: (2023) -
Application values of 3.0T magnetic resonance diffusion weighted imaging for distinguishing liver malignant tumors and benign lesions
por: Li, Ruibin, et al.
Publicado: (2018) -
The ability and utility of diffusion-weighted magnetic resonance imaging with different ‘b’ values in the differentiation of benign from malignant lung lesions
por: Elbir, Şenol Fatih, et al.
Publicado: (2020)